A detailed history of Jones Financial Companies Lllp transactions in United Therapeutics Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 38 shares of UTHR stock, worth $14,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 13 192.31%
Holding current value
$14,131
Previous $4,000 225.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $7,776 - $9,088
25 Added 192.31%
38 $13,000
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $2,967 - $4,147
13 New
13 $4,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.